Intravenous Dexamethasone vs. Placebo as Adjunctive Therapy to Reduce the Recurrence Rate of Acute Migraine Headaches: A Multicenter Double-blind Placebo-controlled Randomized Clinical Trial

Recurrence Rate ◽

Adjunctive Therapy ◽

Acute Migraine ◽

Double Blind ◽

Double Blind Placebo ◽

Migraine Headaches

Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial

The American Journal of Emergency Medicine ◽

10.1016/j.ajem.2007.03.029 ◽

2008 ◽

Vol 26 (2) ◽

pp. 124-130 ◽

Cited By ~ 34

Author(s):

David Donaldson ◽

Ryan Sundermann ◽

Raymond Jackson ◽

Aveh Bastani

Keyword(s):

Clinical Trial ◽

Recurrence Rate ◽

Adjunctive Therapy ◽

Acute Migraine ◽

Migraine Headaches ◽

Double Blinded

Faculty of 1000 evaluation for Double-blind placebo-controlled randomized clinical trial on the efficacy of Aerosal® in the treatment of sub-obstructive adenotonsillar hypertrophy and related diseases.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718129305.793485934 ◽

2013 ◽

Author(s):

Iain Nixon ◽

Hannah Dixon

Keyword(s):

Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Adenotonsillar Hypertrophy

Oral Azitromycin Prophylaxis, 250 Mg Once Daily Three-Times a Week, in Primary Antibody Deficiencies: A Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3235640 ◽

2018 ◽

Author(s):

Cinzia Milito ◽

Federica Pulvirenti ◽

Francesco Cinetto ◽

Vassilios Lougaris ◽

Annarosa Soresina ◽

...

Keyword(s):

Clinical Trial ◽

Primary Antibody ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Primary Antibody Deficiencies

Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Pain and Therapy ◽

10.1007/s40122-021-00275-8 ◽

2021 ◽

Author(s):

Xiaofen Liu ◽

Jun Hu ◽

Xianwen Hu ◽

Rui Li ◽

Yun Li ◽

...

Keyword(s):

Clinical Trial ◽

Visceral Pain ◽

Double Blind ◽

Saffron improves life and sleep quality, glycemic status, lipid profile and liver function in diabetic patients: A double‐blind, placebo‐controlled, randomized clinical trial

International Journal of Clinical Practice ◽

10.1111/ijcp.14334 ◽

2021 ◽

Author(s):

Aynaz Tajaddini ◽

Neda Roshanravan ◽

Majid Mobasseri ◽

Aydin Aeinehchi ◽

Pouria Sefid‐Mooye Azar ◽

...

Keyword(s):

Clinical Trial ◽

Liver Function ◽

Sleep Quality ◽

Lipid Profile ◽

Diabetic Patients ◽

Glycemic Status ◽

Double Blind ◽

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder

Double-blind placebo-controlled randomized clinical trial of verapamil for chronic rhinosinusitis with nasal polyps

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2016.11.014 ◽

2017 ◽

Vol 140 (1) ◽

pp. 271-273 ◽

Cited By ~ 7

Author(s):

Marcel M. Miyake ◽

Angela Nocera ◽

Patricia Levesque ◽

Rong Guo ◽

Christine A. Finn ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Rhinosinusitis ◽

Nasal Polyps ◽

Double Blind ◽

Effects of Terazosin and Tolterodine on Ureteral Stent Related Symptoms: A Double-Blind Placebo-Controlled Randomized Clinical Trial

International braz j urol ◽

10.1590/s1677-5538.ibju.2013.06.09 ◽

2013 ◽

Vol 39 (6) ◽

pp. 832-840 ◽

Cited By ~ 19

Author(s):

Ali Tehranchi ◽

Yousef Rezaei ◽

Hamidreza Khalkhali ◽

Mahdi Rezaei

Keyword(s):

Clinical Trial ◽

Ureteral Stent ◽

Double Blind ◽

Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: Results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane

The Prostate ◽

10.1002/(sici)1097-0045(199610)29:4<199::aid-pros1>3.0.co;2-7 ◽

1996 ◽

Vol 29 (4) ◽

pp. 199-208 ◽

Cited By ~ 33

Author(s):

Albert Radlmaier ◽

Hans U. Eickenberg ◽

Matthew S. Fletcher ◽

Richard O. Fourcade ◽

José M. Reis Santos ◽

...

Keyword(s):

Clinical Trial ◽

Benign Prostatic Hyperplasia ◽

Aromatase Inhibitor ◽

Prostatic Hyperplasia ◽

Aromatase Inhibition ◽

Double Blind ◽

Orally administered mixed carotenoids protect human skin against ultraviolet A‐induced skin pigmentation: A double‐blind, placebo‐controlled, randomized clinical trial

Photodermatology Photoimmunology & Photomedicine ◽

10.1111/phpp.12541 ◽

2020 ◽

Vol 36 (3) ◽

pp. 219-225 ◽

Cited By ~ 1

Author(s):

Sudhir M. Baswan ◽

Alessandra Marini ◽

Allison E. Klosner ◽

Thomas Jaenicke ◽

Jesse Leverett ◽

...

Keyword(s):

Clinical Trial ◽

Human Skin ◽

Skin Pigmentation ◽

Ultraviolet A ◽

Double Blind ◽